Considering the clinical effectiveness of AIT in IgE-associated allergic diseases, several trials, often uncontrolled, investigated the efficacy of AIT for patients with “extrinsic” AD and reported overall controversial results [9, 113, 114]. This evidence concerns the gene IGHE and Alzheimer disease.